Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been dosed in Australia in a first-in-human (FIH) phase…
Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease
The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD). The PH-ILD position statement, featuring a version for…
The Indian Chest Society (ICS) Announces NAPCON 2023
The Indian Chest Society (ICS) is delighted to announce that NAPCON 2023, the most prestigious annual national conference on pulmonary diseases, will be held at Delhi’s Hotel Ashoka Chanakyapuri from Thursday, October 5th, 2023 to Sunday, October 8th, 2023. As…
Preserving Tradition and Health: The Magic of Pure Mustard Oil
The author of this article is Mr. Ajay Data, Health Expert and Managing Director, Data Group of Industries Mustard oil has been a staple in our kitchens and medicine cabinets for centuries. The mustard plant, which grows across India, yields…
Rising to the Challenge: “Stop Sneeze to Wheeze” Takes on Allergic Rhinitis and Asthma with a Unified Approach
As millions around the world suffer from the debilitating effects of Allergic Rhinitis and its progression into Asthma, Alkem Laboratories Ltd. has taken a stand. Its recently launched “Stop Sneeze to Wheeze” initiative is poised to revolutionize how these conditions…
A Breakthrough in Respiratory Care: Alniche Lifesciences’ Innovative Product Expansion
India’s growing air pollution and rapid urbanization have led to a rise in respiratory conditions, demanding efficient solutions to address the various challenges faced by the population. Alniche Lifesciences, an emerging leader in the pharmaceutical industry, recognizes this need and…
